Ernane Souza, PhD, R Ph
About Ernane Souza, PhD, R Ph
Ernane Souza, PhD, R Ph, serves as the Assistant Director of Translational PKPD and DMPK at Supernus Pharmaceuticals, Inc. He has extensive experience in clinical pharmacology and drug development, with a background in various academic and pharmaceutical roles across multiple countries.
Work at Supernus Pharmaceuticals
Ernane Souza currently serves as the Assistant Director of Translational PKPD and DMPK at Supernus Pharmaceuticals, Inc. since 2022. In this role, he focuses on the integration of pharmacokinetics and pharmacodynamics in drug development processes. His responsibilities include overseeing the application of physiologically-based pharmacokinetics (PBPK) and pharmacokinetics/pharmacodynamics (PK/PD) modeling to optimize drug formulations and therapeutic strategies.
Education and Expertise
Ernane Souza holds a Ph.D. in Pharmaceutical Sciences from the University of Iowa, where he studied Medicinal Chemistry from 2013 to 2018. He also completed a Postdoctoral Fellowship in Clinical Pharmacy Translational Science at the University of Michigan from 2018 to 2020. His educational background includes a Bachelor of Pharmacy from the Federal University of Juiz de Fora and a visiting scholar program at the University of Salamanca, Spain. He has developed expertise in artificial intelligence applications for ADMET optimization and early drug development.
Background
Ernane Souza has a diverse professional background in pharmaceutical sciences and clinical research. He worked as a Graduate Research Assistant at the University of Iowa from 2013 to 2018 and as a Postdoctoral Research Fellow at the University of Michigan from 2018 to 2020. His earlier roles include positions at the Federal University of Juiz de Fora and the University of Salamanca, where he contributed to research in clinical pharmacology and pharmaceutical chemistry.
Achievements
Throughout his career, Ernane Souza has gained significant experience in designing and managing clinical trials. He specializes in LC-MS/MS bioanalytical method development and has a broad range of therapeutic expertise, including cardiovascular pharmacotherapy, anticoagulation, nephrology, infectious diseases, and neurologic and psychiatric pharmacotherapy. His work has contributed to advancements in drug development and optimization in various therapeutic areas.